Status:
COMPLETED
Postmenopausal Estrogen/Progestin Interventions (PEPI)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsors:
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Bone Diseases
Cardiovascular Diseases
Eligibility:
FEMALE
45-64 years
Phase:
PHASE3
Brief Summary
To assess the effects of various postmenopausal estrogen replacement therapies on selected cardiovascular risk factors, including high density lipoprotein cholesterol, systolic blood pressure, fibrino...
Detailed Description
BACKGROUND: The life expectancy of American women is 78 years. More than one-third of those years are postmenopausal, during which time the risk of coronary heart disease is increased. The current Un...
Eligibility Criteria
Postmenopausal women, ages 45 to 64. One third of the subjects had had a hysterectomy.
Key Trial Info
Start Date :
September 1 1987
Trial Type :
INTERVENTIONAL
End Date :
October 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000466
Start Date
September 1 1987
End Date
October 1 2000
Last Update
May 13 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.